ATH
Click for more information
0.00% 0.3¢ alterity therapeutics limited

Ann: Approval of PBT2 Orphan Designation for Huntingtons Disease, page-15

  1. interestingtome
    1,847 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    01/06/15
    13:55
    Post #: 15389659
    Post from ymb-

    Investor Communication
    by hemingwayplay • 1 hour 15 minutes ago

    It takes a long time to learn the PRAN language but those who know it know that this latest release speaks volumes about what's coming in the next couple of months. Every penny is going into this stock tomorrow. Strong Buy as always.

    Sentiment: Strong Buy
    PBT Price at posting: 20.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $33 11K

Buyers (Bids)

No. Vol. Price($)
37 46612444 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126748541 18
View Market Depth
Last trade - 10.00am 12/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.